CME/CE

Overview
This 1.5 day class will review the latest evidence and research on HDL metabolism and functionality, targets of therapy, and existing and novel HDL raising therapies. Participants will be expected to improve their HDL knowledge and competence, ex-pand the depth of their understanding of lipid science, and help their patients make informed decisions about lipid therapies to reduce the risk of cardiovascular disease.

Target Audience
This program is intended for physicians, registered dietitians, pharmacists, registered nurses, nurse practitioners, physician assistants, researchers and other specialists with advanced knowledge and experience in preventive cardiology.

Course Curriculum

HDL Epidemiology and History of Development into a Therapeutic Target
HDL Metabolism from the Macrophage to the Intestines
Genetic HDL Deficieny Disorders: Insight into HDL Metabolism
The Link Between Triglyceride and HDL Metabolism
Measurement of HDL Subfractions and Function
HDL Proteomics and Lipidomics: Implications for Functionality
Current Therapies to Elevate HDL - Update on Clinical Trials
Lifestyle Changes and HDL
Novel Therapeutic Targets to Raise HDL
New Drug Therapies to Elevate HDL: Challenges and Opportunity

Learning Objectives
At the conclusion of this activity, participants should be able to:

Evaluate the role of HDL-C in reducing cardiovascular events and rates of atherosclerotic disease progression;
Describe the mechanisms involved in the production, metabolism, and functionality of HDL including how they relate to atherogenesis;
Identify the genetic causes of low and high serum HDL-C including the clinical and research implications of these genetic disorders;
Review the role of HDL subfractions and apolipoproteins as risk factors;
Outline the various HDL receptors and metabolic pathways and their pleiotropic effects;
Compare the relative effectiveness of existing treatments to raise HDL and reduce CVD risk;
Discuss recent evidence regarding the utility of HDL as a target for CVD risk modification including the clinical implications or patient management.

For Registered Nurses and Nurse Practitioners only

Provide appropriate care and counsel for patients and their families

Accreditation

CME credit provided by the National Lipid Association

Physicians
The National Lipid Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education. The National Lipid Association designates this live activity for a maximum of 10.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Physician Assistants
NCCPA accepts AMA PRA Category I Credit™ from organizations accredited by ACCME.

CE Credit provided by Postgraduate Institute for Medicine

Pharmacists
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Universal Activity Number - 0809-9999-12-119-L01-P (Knowledge).
Postgraduate Institute for Medicine designates this continuing education activity for 10.75 contact hour(s) (1.075 CEUs) of the Accreditation Council for Pharmacy Education.

Nursing
This educational activity for 10.7 contact hours is provided by Postgraduate Institute for Medicine. Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. Postgraduate Institute for Medicine is approved by the California Board of Registered Nursing, Provider Number 13485 for 10.7 contact hours.

Dietitians
The following program has been submitted for approval to the Commission on Dietetic Registration (CDR) for 10.5 credits.

Criteria for Success
Statements of credit will be awarded based on the participant's attendance and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/ claimed credit form at www.lipid.org/cme.

Disclosure Statement
It is the policy of NLA to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by NLA prior to accreditation of the activity. NLA planners and reviewers have no relevant financial relationships to disclose.

Commercial Support
Full notification of commercial support will be provided in the activity syllabus.